Hormone replacement therapy after risk-reducing salpingo-oophorectomy minimises endocrine and sexual problems: A prospective study

There has been some doubts raised in earlier studies about the efficacy of hormone replacement therapy (HRT) in reducing endocrine and sexual problems in women who have undergone a risk-reducing salpingo-oophorectomy (RRSO).

Source: European Journal of Cancer - August 14, 2017 Category: Cancer & Oncology Authors: Ravi F.M. Vermeulen, Marc van Beurden, Jacobien M. Kieffer, Eveline M.A. Bleiker, Heiddis B. Valdimarsdottir, Leon F.A.G. Massuger, Marian J.E. Mourits, Katja N. Gaarenstroom, Eleonora B.L. van Dorst, Hans W.H.M. van der Putten, Neil K. Aaronson Tags: Original Research Source Type: research